FMP
Jun 18, 2025 9:00 AM - Danny Green
Image credit: Google Images
TechTarget, Inc. (NASDAQ:TTGT) is a prominent player in the technology media and purchase intent-driven marketing and sales services industry. The company provides specialized online content and services that help technology vendors reach targeted audiences. As a majority shareholder, Informa PLC plays a significant role in TTGT's operations and strategic direction. TTGT's competitors include companies like Gartner and Forrester Research, which also offer technology-related insights and services.
On June 19, 2025, TTGT is set to release its quarterly earnings, with Wall Street estimating an earnings per share (EPS) of $0.08 and projected revenue of approximately $106.2 million. This comes after Informa TechTarget announced that its revenues for the first five months of 2025 align with the guidance for the first half of the year. This update precedes Informa PLC's Annual General Meeting Trading Update on June 17, 2025.
The price-to-sales ratio of 2.11 suggests that investors are still willing to pay $2.11 for every dollar of sales, showing some confidence in the company's revenue-generating potential. TTGT's financial structure reveals a debt-to-equity ratio of about 1.72, indicating a higher reliance on debt compared to equity. This could pose risks if the company cannot manage its debt effectively. However, the current ratio of approximately 10.49 suggests strong liquidity, meaning TTGT is well-positioned to cover its short-term liabilities. The enterprise value to sales ratio of 2.77 and enterprise value to operating cash flow ratio of 10.53 provide additional insights into the company's valuation and cash flow efficiency.
Jun 18, 2025 4:00 AM - Andrew Wynn
Compass Diversified Holdings (NYSE:CODI) is a company that manages a diverse portfolio of businesses across various industries. On June 18, 2025, CODI reported earnings per share of $0.30, which was below the expected $0.45. The company's revenue also fell short, coming in at $487.6 million compared...
Jun 18, 2025 7:00 AM - Tony Dante
Regencell Bioscience Holdings Limited (NASDAQ:RGC) is a company involved in the development of traditional Chinese medicine-based treatments. Currently, RGC is trading at $610.50, but analysts have set a target price of approximately $0.22. This stark difference of -99.96% suggests a highly pessimis...